Clinical Audit on the Managment in Assiut University Children Hospital
|ClinicalTrials.gov Identifier: NCT03281863|
Recruitment Status : Unknown
Verified September 2017 by Patricia reda hanna, Assiut University.
Recruitment status was: Not yet recruiting
First Posted : September 13, 2017
Last Update Posted : September 15, 2017
|Condition or disease||Intervention/treatment|
|Rheumatic Fever||Diagnostic Test: C reactive protein, anti streptolysin o antibody test ,erythrocyte sedimentation rate|
Acute rheumatic fever,an auto immune response to Group A streptococcus infection of the upper respiratory tract,may result in carditis.when the inflammation leads to permenant damage of the valves the individual has rheumatic heart disease.
Recurrences of rheumatic fever are likely in the absence of preventive measures and may cause further cardiac valve and muscle damage,leading to heart failure,stroke and premature death.bacterial endocarditis is also a complication.
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Clinical Audit on the Managment of Rheumatic Fever in Assiut University Children Hospital|
|Estimated Study Start Date :||October 1, 2017|
|Estimated Primary Completion Date :||September 29, 2018|
|Estimated Study Completion Date :||September 29, 2018|
- Diagnostic Test: C reactive protein, anti streptolysin o antibody test ,erythrocyte sedimentation rate
Throat culture to detect the causative organismOther Name: Throat culture
- laboratory investigations (ASOt , ESR . CRP) [ Time Frame: One year from October 2017 to september 2018 ]laboratory investigations that measure the inflammation process will be used and the target that the ASOt not increase 1/400
- clinical measures [ Time Frame: One year from October 2017 to september 2018 ]improvement of arthritis if found